kt 6149 has been researched along with Colonic Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Bruijn, EA; Dirix, LY; Gheuens, EE; van der Heyden, S; van Oosterom, AT | 1 |
| Lee, JH; Naito, M; Tsuruo, T | 1 |
| Mikami, K; Shirakusa, T; Tsuruo, T | 1 |
| Asami, N; Inaba, M; Morimoto, M; Sudo, Y; Tsuruo, T | 1 |
| Hattori, T; Jinushi, K; Kim, R; Kirihara, Y; Niimoto, M; Nishiyama, M; Nosoh, Y; Saeki, K; Saeki, T; Takagami, S | 1 |
| Hattori, T; Jinushi, K; Kim, R; Kirihara, Y; Niimoto, M; Nishiyama, M; Saeki, T; Takagami, S; Toge, T | 1 |
1 review(s) available for kt 6149 and Colonic Neoplasms
| Article | Year |
|---|---|
[DT-diaphorase].
Topics: Antibiotics, Antineoplastic; Aziridines; Colonic Neoplasms; Cytochrome Reductases; Cytochrome-B(5) Reductase; Drug Screening Assays, Antitumor; Humans; Indolequinones; Indoles; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Stomach Neoplasms; Tumor Cells, Cultured; Xanthine Dehydrogenase; Xanthine Oxidase | 1997 |
5 other study(ies) available for kt 6149 and Colonic Neoplasms
| Article | Year |
|---|---|
Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patterns.
Topics: Animals; Colonic Neoplasms; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Kinetics; Mitomycin; Mitomycins; Ovarian Neoplasms; Rats; Tumor Cells, Cultured | 1994 |
Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
Topics: Buthionine Sulfoximine; Colonic Neoplasms; Cysteine; Cytochrome P-450 Enzyme System; DNA, Neoplasm; Drug Interactions; Drug Resistance; Glutathione; Humans; Methionine Sulfoximine; Mitomycin; Mitomycins; Oxidation-Reduction; Sulfhydryl Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation | 1990 |
[Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay].
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Humans; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Neoplasm Transplantation; Remission Induction; Stomach Neoplasms; Subrenal Capsule Assay; Weight Loss | 1989 |
[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Infusions, Parenteral; Lethal Dose 50; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Stomach Neoplasms | 1988 |